| Serial Number | 90730515 |
| Word Mark | ENTRAYNIA |
| Filing Date | Monday, May 24, 2021 |
| Status | 733 - FOURTH EXTENSION - GRANTED |
| Status Date | Tuesday, October 1, 2024 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | Tuesday, August 23, 2022 |
| Goods and Services | Pharmaceutical preparations for the treatment of viral diseases; Pharmaceutical preparations for the treatment of viral infections; Pharmaceutical preparations for the treatment of circadian rhythm diseases and disorders; Pharmaceutical preparations for the treatment of Non-24-Hour Sleep-Wake Disorder; Pharmaceutical preparations for the treatment of jet lag disorder; Pharmaceutical preparations for the treatment of Smith-Magenis Syndrome; Pharmaceutical preparations for the treatment of Delayed Sleep Phase Disorder; Pharmaceutical preparations for the treatment of bipolar disorder; Pharmaceutical preparations for the treatment of schizophrenia; Pharmaceutical preparations for the treatment of atopic dermatitis; Pharmaceutical preparations for the treatment of pruritus; Pharmaceutical preparations for the reduction of cravings for alcohol, food, nicotine, opioids, or opiates; Pharmaceutical preparations for the treatment of gastroparesis; Pharmaceutical preparations for the treatment of motion sickness; Pharmaceutical preparations for the treatment of hematologic malignancies; Pharmaceutical preparations for the treatment of fatigue; Pharmaceutical preparations for the treatment of narcolepsy; Pharmaceutical preparations for the treatment of levodopa-induced dyskinesias in Parkinson's Disease; Pharmaceutical preparations for the treatment of viral pneumonia; Pharmaceutical preparations for the treatment of social anxiety disorder and social anxiety disorder performance-only subtype; Pharmaceutical preparations for the treatment of respiratory distress, acute respiratory distress syndrome, and inflammatory lung injury; Pharmaceutical preparations for the treatment of gastric motility and gastric emptying disorders; Pharmaceutical preparations for the treatment of cancer; Pharmaceutical preparations for the treatment of multiple myeloma; Pharmaceutical preparations for facilitating emergence from general anesthesia; Pharmaceutical preparations for improving cognition; Pharmaceutical preparations, namely, antivirals |
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Thursday, August 19, 2021 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| Party Name | Vanda Pharmaceuticals Inc. |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 03 - Corporation |
| Address | Washington, DC 20037 |
| Party Name | Vanda Pharmaceuticals Inc. |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 03 - Corporation |
| Address | Washington, DC 20037 |
| Event Date | Event Description |
| Thursday, May 27, 2021 | NEW APPLICATION ENTERED |
| Friday, February 11, 2022 | NON-FINAL ACTION WRITTEN |
| Thursday, August 19, 2021 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Friday, February 4, 2022 | ASSIGNED TO EXAMINER |
| Friday, February 11, 2022 | NON-FINAL ACTION E-MAILED |
| Friday, February 11, 2022 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Thursday, July 14, 2022 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Thursday, July 14, 2022 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Friday, July 15, 2022 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Thursday, July 21, 2022 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Wednesday, August 3, 2022 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Tuesday, August 23, 2022 | PUBLISHED FOR OPPOSITION |
| Tuesday, August 23, 2022 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Tuesday, October 18, 2022 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
| Friday, October 13, 2023 | SOU EXTENSION 2 GRANTED |
| Monday, April 3, 2023 | SOU TEAS EXTENSION RECEIVED |
| Monday, April 3, 2023 | SOU EXTENSION 1 FILED |
| Monday, April 3, 2023 | SOU EXTENSION 1 GRANTED |
| Wednesday, April 5, 2023 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Friday, October 13, 2023 | SOU TEAS EXTENSION RECEIVED |
| Friday, October 13, 2023 | SOU EXTENSION 2 FILED |
| Friday, February 2, 2024 | SOU EXTENSION 3 FILED |
| Tuesday, October 17, 2023 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Friday, February 2, 2024 | SOU TEAS EXTENSION RECEIVED |
| Friday, February 2, 2024 | SOU EXTENSION 3 GRANTED |
| Tuesday, October 1, 2024 | SOU EXTENSION 4 GRANTED |
| Wednesday, March 12, 2025 | SOU TEAS EXTENSION RECEIVED |
| Tuesday, October 1, 2024 | SOU EXTENSION 4 FILED |
| Tuesday, February 6, 2024 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Tuesday, October 1, 2024 | SOU TEAS EXTENSION RECEIVED |
| Tuesday, October 1, 2024 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |